Cell-assembled extracellular matrix (CAM): a human biopaper for the biofabrication of pre-vascularized tissues able to connect to the host circulation in vivo
Source abstract
Abstract
Abstract When considering regenerative approaches, the efficient creation of a functional vasculature, that can support the metabolic needs of bioengineered tissues, is essential for their survival after implantation. However, it is widely recognized that the post-implantation microenvironment of the engineered tissues is often hypoxic due to insufficient vascularization, resulting in ischemia injury and necrosis. This is one of the main limitations of current tissue engineering applications aiming at replacing significant tissue volumes. Here, we have explored the use of a new biomaterial, the cell-assembled extracellular matrix (CAM), as a biopaper to biofabricate a vascular system. CAM sheets are a unique, fully biological and fully human material that has already shown stable long-term implantation in humans. We demonstrated, for the first time, the use of this unprocessed human ECM as a microperforated biopaper. Using microvalve dispensing bioprinting, concentrated human endothelial cells (30 millions ml −1 ) were deposited in a controlled geometry in CAM sheets and cocultured with HSFs. Following multilayer assembly, thick ECM-based constructs fused and supported the survival and maturation of capillary-like structures for up to 26 d of culture. Following 3 weeks of subcutaneous implantation in a mice model, constructs showed limited degradative response and the pre-formed vasculature successfully connected with the host circulatory system to establish active perfusion.This mechanically resilient tissue equivalent has great potential for the creation of more complex implantable tissues, where rapid anastomosis is sine qua non for cell survival and efficient tissue integration.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Concise review: tailoring bioengineered scaffolds for stem cell applications in tissue engineering and regenerative medicine10.5966/sctm.2014-0203 ↗
2. Engineering principles of clinical cell-based tissue engineering10.2106/00004623-200407000-00029 ↗
3. The pivotal role of vascularization in tissue engineering10.1146/annurev-bioeng-071812-152428 ↗
4. Neovascularization in tissue engineering10.3390/cells1041246 ↗
5. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment
6. Angiogenesis in tissue engineering: as nature Intended?10.3389/fbioe.2020.00188 ↗
7. Engineering vascularized skeletal muscle tissue10.1038/nbt1109 ↗
8. Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature10.1089/ten.tea.2008.0314 ↗
9. Bio-engineering a tissue flap utilizing a porous scaffold incorporating a human induced pluripotent stem cell-derived endothelial cell capillary network connected to a vascular pedicle10.1016/j.actbio.2019.05.067 ↗
10. Mature vessel networks in engineered tissue promote graft-host anastomosis and prevent graft thrombosis10.1073/pnas.1814238116 ↗
11. Inosculation and perfusion of pre-vascularized tissue patches containing aligned human microvessels after myocardial infarction10.1016/j.biomaterials.2016.04.031 ↗
12. Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts10.1089/ten.tea.2009.0491 ↗
13. Geometric control of vascular networks to enhance engineered tissue integration and function10.1073/pnas.1217796110 ↗
14. Morphogenesis of 3D vascular networks is regulated by tensile forces10.1073/pnas.1522273113 ↗
15. Metre-long cell-laden microfibres exhibit tissue morphologies and functions10.1038/nmat3606 ↗
16. Microfabricated blood vessels undergo neoangiogenesis10.1016/j.biomaterials.2017.05.012 ↗
17. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
18. 3D bioprinting for engineering complex tissues10.1016/j.biotechadv.2015.12.011 ↗
19. 3D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends10.1016/j.gendis.2017.10.002 ↗
20. Bioprinting vasculature: materials, cells and emergent techniques10.3390/ma12172701 ↗
21. Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization10.1016/j.actbio.2014.01.028 ↗
22. In vivo evaluation and comparison of collagen, acetylated collagen and collagen/glycosaminoglycan composite films and sponges as candidate biomaterials10.1016/0142-9612(90)90148-J ↗
23. A comparison of chitosan and collagen sponges as hemostatic dressings10.1177/0883911506060201 ↗
24. The pathology of the foreign body reaction against biomaterials10.1002/jbm.a.35958 ↗
25. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery10.1016/j.biomaterials.2008.11.011 ↗
26. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study10.1016/S0140-6736(09)60248-8 ↗
27. Tissue-engineered blood vessel for adult arterial revascularization10.1056/NEJMc071536 ↗
28. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access10.1016/j.jvs.2013.08.018 ↗
29. Characterization of a cell-assembled extracellular matrix and the effect of the devitalization process10.1016/j.actbio.2018.10.006 ↗
30. Human textiles: a cell-synthesized yarn as a truly ‘bio’ material for tissue engineering applications10.1016/j.actbio.2020.01.037 ↗
31. In vivo remodeling of human cell-assembled extracellular matrix yarns10.1016/j.biomaterials.2021.120815 ↗
32. Microvalve-based bioprinting-process, bio-inks and applications10.1039/C6BM00861E ↗
33. Endothelial cell compatibility testing of three different Pellethanes10.1002/jbm.820271104 ↗
34. ISO 10993-5:2009 Biological evaluation of medical devices—part 5: tests for in vitro cytotoxicity
35. Ulex europaeus I lectin as a marker for vascular endothelium in human tissues
36. The extracellular matrix and blood vessel formation: not just a scaffold: angiogenesis review series10.1111/j.1582-4934.2007.00031.x ↗
37. The role of pericytes in blood-vessel formation and maintenance10.1215/S1152851705000232 ↗
38. Creation of long-lasting blood vessels10.1038/428138a ↗
39. Vascularization in tissue engineering10.1016/j.tibtech.2008.04.009 ↗
40. 3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days10.22203/eCM.v026a04 ↗
41. Neonatal human dermal fibroblasts immobilized in RGD-alginate induce angiogenesis10.3727/096368913X670183 ↗
42. Alkaline phosphatase dual-binding sites for collagen dictate cell migration and microvessel assembly in vitro10.1002/jcb.29835 ↗
43. Human tissue-engineered blood vessels for adult arterial revascularization10.1038/nm1364 ↗
44. Vascular tissue engineering: progress, challenges, and clinical promise10.1016/j.stem.2018.03.014 ↗
45. Human dermal fibroblasts: a potential cell source for endothelialization of vascular grafts10.1016/j.avsg.2009.03.007 ↗
46. Tissue-engineered skin substitutes10.1517/14712598.2.1.25 ↗
47. Biologic filler using human fibroblasts and placenta extracts10.1097/SCS.0b013e31822e5c5e ↗
48. Clinical-instrumental and morphological evaluation of the effect of autologous dermal fibroblasts administration10.1002/term.1976 ↗
49. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, phase III clinical trial10.1111/j.1524-4725.2007.33060.x ↗
50. Extracellular matrix-based materials for regenerative medicine10.1038/s41578-018-0023-x ↗
51. Biopolymer-based functional composites for medical applications10.1016/j.progpolymsci.2016.12.003 ↗
52. Targeted proteomics effectively quantifies differences between native lung and detergent-decellularized lung extracellular matrices10.1016/j.actbio.2016.09.043 ↗
53. Consequences of ineffective decellularization of biologic scaffolds on the host response10.1016/j.biomaterials.2011.10.054 ↗
54. Upgrading prevascularization in tissue engineering: a review of strategies for promoting highly organized microvascular network formation10.1016/j.actbio.2019.03.016 ↗
55. Controlling shear stress in 3D bioprinting is a key factor to balance printing resolution and stem cell integrity10.1002/adhm.201500677 ↗
56. Improved vascular organization enhances functional integration of engineered skeletal muscle grafts10.1073/pnas.1017825108 ↗
57. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue10.1073/pnas.0908381106 ↗
58. Proangiogenic scaffolds as functional templates for cardiac tissue engineering10.1073/pnas.1006442107 ↗
59. Functional porous hydrogels to study angiogenesis under the effect of controlled release of vascular endothelial growth factor10.1016/j.actbio.2012.05.019 ↗
60. Laser-capture microdissection10.1038/nprot.2006.85 ↗
61. Femtosecond laser ablation enhances cell infiltration into three-dimensional electrospun scaffolds10.1016/j.actbio.2012.04.023 ↗
62. Control of the formation of vascular networks in 3D tissue engineered constructs10.1016/j.biomaterials.2012.10.009 ↗
63. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering10.1016/j.biomaterials.2010.01.105 ↗
64. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts10.1161/CIRCULATIONAHA.107.757286 ↗
65. Preparation of three-dimensional vascularized MSC cell sheet constructs for tissue regeneration10.1155/2014/301279 ↗